Jounce Therapeutics inc

Officers & Directors

1. Richard Murray - President and CEO
2. Elizabeth Trehu, M.D. - Chief Medical Officer
3. Kim Drapkin, Ph.D. - Senior Vice President, Research and Development
4. Charles Morris, M.D. - Senior Vice President, Clinical Development and Translational Medicine
5. Karen Gilmore - Chief Financial Officer
6. Marina Pecoraro-Rao, Ph.D. - Vice President, Quality Assurance
Michael Venuti, Ph.D. - Vice President, Intellectual Property

Board of Directors:

1. Cary Pfeffer, M.D. (Chairman) - Partner at Third Rock Ventures
2. Richard Murray - President and CEO of Jounce Therapeutics
3. Linda Bain - Chief Financial Officer of Relay Therapeutics
4. Barbara Duncan - Independent Board Director
5. Mark Goldberg, M.D. - Partner at Index Ventures
6. Catherine Sohn - Managing Director at Fidelity Management and Research Company
John Whelan - Senior Vice President and Chief Strategy Officer at Alexion Pharmaceuticals.

Jounce Therapeutics inc currently has 125 employees.

Business Description

Officers & Directors

JNCE Management Effectiveness

JNCE Revenue per Employee

JNCE Income per Employee

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.